VERTEX PHARMACEUTICALS INC / MA (VRTX) Revenue 2016–2025
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$12.0BFY2025 · since FY2016: $1.7B → $12.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $12.0B | +8.9% |
| FY2024 | $11.0B | +11.7% |
| FY2023 | $9.9B | +10.5% |
| FY2022 | $8.9B | +17.9% |
| FY2021 | $7.6B | +22.1% |
| FY2020 | $6.2B | +49.1% |
| FY2019 | $4.2B | +36.6% |
| FY2018 | $3.0B | +22.5% |
| FY2017 | $2.5B | +46.2% |
| FY2016 | $1.7B | — |
Source: SEC XBRL filings · For reference only · Not investment advice